Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of AL, DHA-PPQ, and As-Pyr for Uncomplicated Malaria in Children (CHIMIO2)
NCT04778813Phase 4Unknown
- Sponsor
- Centre National de Recherche et de Formation sur le Paludisme
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin + piperaquine, artesunate + pyronaridine in Plasmodium falciparum malaria, sponsored by Centre National de Recherche et de Formation sur le Paludisme. Status: unknown.
02
Drugs
dihydroartemisinin + piperaquineartesunate + pyronaridine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT04778813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04778813.